PTGX 64.11 ▼ -0.91% Live Trading Data - Stocknear

Protagonist Therapeutics ...

NASDAQ: PTGX · Real-Time Price · USD
64.11
-0.59 (-0.91%)
At close: Sep 26, 2025, 11:04 AM
-0.91%
Bid 46.9
Market Cap 3.99B
Revenue (ttm) 203.63M
Net Income (ttm) 52.04M
EPS (ttm) 0.72
PE Ratio (ttm) 89.05
Forward PE -6595
Analyst Buy
Dividends n/a
Ask 82.34
Volume 219,746
Avg. Volume (20D) 991,637.8
Open 65.46
Previous Close 64.70
Day's Range 64.03 - 65.55
52-Week Range 33.31 - 66.70
Beta 2.22
Ex-Dividend Date n/a

About PTGX

undefined

Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol PTGX
Website n/a
Full Company Profile

Analyst Forecast

According to 0 analyst ratings, the average rating for PTGX stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.

Stock Forecasts
Protagonist Therapeutics Inc. is scheduled to release its earnings on Nov 6, 2025, after market closes.
Analysts project revenue of ... Unlock content with Pro Subscription
6 months ago
+45.89%
Protagonist Therapeutics shares are trading higher... Unlock content with Pro Subscription
6 months ago
+2.42%
Protagonist Therapeutics shares are trading higher after the company announced its Polycythemia Vera Phase 3 study with Takeda met all its key goals.